The Swiss Glucose Variability Study
|ClinicalTrials.gov Identifier: NCT01426737|
Recruitment Status : Unknown
Verified August 2011 by University of Zurich.
Recruitment status was: Recruiting
First Posted : August 31, 2011
Last Update Posted : August 31, 2011
The purpose of this study is to explore long term glucose variability of a combination therapy of metformin and vildagliptin compared to a metformin - gliclazide combination.
Multicenter, randomized, open, parallel group, Phase IV study, of 18 months duration.
- Trial with medicinal product
|Condition or disease||Intervention/treatment||Phase|
|Type 2 Diabetes||Drug: Vildagliptin||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Swiss Glucose Variability Study|
|Study Start Date :||April 2011|
|Estimated Primary Completion Date :||January 2013|
|Estimated Study Completion Date :||January 2013|
- Mean amplitude of glycemic excursion as described by Service et al. (1970) calculated from the glucose excursions of the CGMS profiles using MiniMedSolution Software (MedtronicMiniMed). [ Time Frame: 48h ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01426737
|Contact: 01 Studienregister MasterAdmins||+41 (0)44 255 11 11|
|Study Director:||01 Studienregister MasterAdmins||UniversitaetsSpital Zuerich|